. Author manuscript; available in PMC: 2024 May 1.

Published in final edited form as: J Urol. 2023 Feb 27;209(6):1132–1140. doi: 10.1097/JU.0000000000003394

Table 2.

Estimated Spearman Correlation Coefficients at Baseline and 3 Month Follow Up

		PSS	USS	BPI-6	GUPI-4
Baseline	PSS¹	1.0	-	-	-
	USS²	0.53	1.0	-	-
	BPI-6³	0.66	0.45	1.0
	GUPI-4⁴	0.75	0.44	0.73	1.0

Change (3 months)	GRA⁵	0.44	0.28	0.43	0.40
	PSS	-	-	-	-
	USS	0.35	-	-	-
	BPI-6¹	0.45	0.19	-	-
	GUPI-4²	0.74	0.29	0.4	1.0

Percent Change (3 months)	GRA³	0.45	0.27	0.46	0.44
	PSS	1.0	-	-	-
	USS	0.32	1.0	-	-
	BPI-6¹	0.44	0.19	1.0	-
	GUPI-4²	0.74	0.26	0.46	1.0

^1.

Pelvic Pain Severity (0–28)

^2.

Urinary Symptom Severity (0–25)

^3.

Brief Pain Inventory, Item 6 (0–10)

^4.

Genitourinary Pain Index, Item 4 (0–10)

^5.

Global Response Assessment (1–7)